That Minnesota marijuana legalization bill keeps advancing, another senator joins the call for the drug czar to be reinstated to a cabinet-level position, and more.

Marijuana Policy

Minnesota Marijuana Legalization Bill Wins Yet Another Committee Vote. The marijuana legalization bill continues to advance, with the House version, House File 100, winning its seventh committee vote Tuesday in a voice vote at the Workforce Development Finance and Policy Committee. Meanwhile, the Senate version of the bill won its fourth committee vote earlier in the week. But after all those committee votes, the bills are still only about halfway through the committee process. Still, Democratic lawmakers and Gov. Tim Walz (D) are confident the measure will become law before the summer is over.

Drug Policy

At State of the Union, Biden Lays Out Plan to Tackle Fentanyl and Opioid Overdose Epidemic. President Biden outlined his plan "to beat the opioid epidemic" by "disrupting the trafficking, distribution, and sale of fentanyl." That will include increased enforcement at points of entry, intercepting more packages of fentanyl coming through package delivery companies, working diplomatically to address the supply chain abroad, and increasing penalties for fentanyl suppliers. Biden also calling for "expanding access to evidence-based prevention, harm reduction, treatment, and recovery," by delivering more naloxone, ensuring there is more drug treatment in jails and prisons, and expanding access to medications for opioid use disorder.

Another Senator Joins Call for Drug Czar to Be Reinstated as Cabinet Officer. Sen Shelley Moore Capito (R-WV) has joined the list of senators and representatives calling on the Biden administration to restore the director of the Office of National Drug Control Policy (ONDCP—the drug czar's office) to a cabinet-level position. "Elevating the post would enable ONDCP to more effectively coordinate drug control efforts across federal agencies and enhance the Biden administration’s response the opioid epidemic, a public health crisis that killsmore than 100,000 Americans each year." She joins Sen. Ed Markey (D-MA), a member of the U.S. Commission on Combating Synthetic Opioid Trafficking, and Representatives David Trone (D-MD), Brian Fitzpatrick (R-PA), and Annie Kuster (D-NH), co-chairs of the Bipartisan Mental Health and Substance Use Disorder Task Force, who sent a letter to the White House last week urging the drug czar's reinstatement.

International

Myanmar Now a Leading Methamphetamine Producer. Long known for its opium production, Myanmar is now a leading global producer of methamphetamine, according to academic researchers, who cite massive meth seizures in the region (more than 170 tons) and point to armed groups who used to rely on opium revenues switching to meth production after government crackdowns on the poppy. The UN Office on Drugs and Crime puts the value of the regional meth trade at $61 billion a year, and the researchers say organized crime groups are trafficking Myanmar meth to "high value markets," such as Australia, Japan, and New Zealand. 

A Montana bill would block child welfare workers from removing children simply because of a parent's drug use, San Francisco is ready to move forward on safe injection sites, and more.

Medical Marijuana

South Carolina Sees Second Medical Marijuana Bill Filed. A bipartisan medical marijuana bill, the Compassionate Care Act (HB 3486/SB 423), has been filed in both houses this week. It would allow physicians to recommend marijuana to patients with debilitating medical conditions and have them purchase it from state-licensed and -regulated businesses. This is the second medical marijuana bill filed this year. The first, the No Patient Left Alone Act (HB 3215) is similar, but would allow dispensaries to grow their own product. The Compassionate Care Act got through the House last year only to die in the Senate.

Psychedelics

Virginia GOP Lawmakers Block Bill Legalizing Magic Mushrooms for Medical Use. A bill that would allow the use of magic mushrooms for medical purposes, House Bill 1513, has been killed by a subcommittee vote of the House Committee for the Courts of Justice. The bill would have allowed doctors to prescribe the drug for the treatment of depression, PTSD, or end of life anxiety. A bill that would direct Gov. Glenn Youngkin (R) to create a psilocybin study committee remains alive, however.

Child Welfare

Montana Bill Would Block Child Removals Based Solely on Parental Substance Use. An omnibus child protective reforms bill, House Bill 37, aimed at making the removal of children from parental households more difficult includes a provision that bars child welfare workers from removing a child for neglect or abuse based only on "substance use by a parent or guardian, disorderly living conditions, other factors closely related to economic status, or a child's obesity." The GOP-championed bill came after a year of study in the bipartisan Children, Families, Health and Human Services Interim Committee. It passed the House Judiciary Committee Friday and now heads for a House floor vote.

Harm Reduction

San Francisco Mayor Looking Again at Safe Injection Sites. Mayor London Breed (D) said Wednesday that she is working with Supervisor Hillary Ronen (D) to undo a city law that is an obstacle to nonprofits setting up safe injection sites in the city. Breed and other city officials say they are ready to move forward with privately-funded sites, but to do so, the Board of Supervisors will have to repeal a 2020 ordinance that prohibits safe injection sites. While city politicians had been fearful of a federal reaction to a safe injection site, they have been impressed by New York City's pair of safe injection sites that have operated for more than a year without federal harassment. "The Biden administration and the Newsom administration… are not going to throw San Franciscans in jail or cut off our federal funding because we're saving lives and stopping open-air drug use," Ronen told city staffers.

A New York bill would end civil asset forfeiture, a Utah bill would decriminalize fentanyl test strips, and more.

Medical Marijuana

GOP Congressman Files Bill to Protect Gun Rights of Medical Marijuana Patients. The first piece of marijuana reform legislation in the new Congress is a bill that would allow medical marijuana patients to purchase and possess firearms. Sponsored by Rep. Alex Mooney (R-WV), along with Congressional Cannabis Caucus co-chair Rep. Brian Mast (R-FL) and Rep. Thomas Massie (R-KY), the Second Amendment Protection Act seeks to amend federal law around the "sale, purchase, shipment, receipt, or possession of a firearm or ammunition by a user of medical marijuana." Under current law, people who use marijuana can't buy or possess guns because they're considered to be "an unlawful user of or addicted to"a federally controlled substance. Mooney filed a similar bill in 2019, but it did not advance.

Psychedelics

New Hampshire Bill to Legalize Possession of Psychedelics Filed. Rep. Kevin Verville (R) has filed House Bill 328, which states that the "possession or use of a hallucinogenic drug by a person 21 years of age or older shall not be an offense."It would also reduce penalties for LSD manufacturing and possession by people under 21. The bill does not name specific drugs, but state statute lists mescaline, peyote, psilocybin, and LSD as examples of hallucinogenic substances. The bill has been referred to the House Criminal Justice and Public Safety Committee.

Asset Forfeiture

New York Bill Would End Civil Asset Forfeiture and Opt State Out of Federal Forfeiture Program. Assemblywoman Pamela Hunter (D) and eight Democratic cosponsors have filed Assembly Bill 641, which would end civil asset forfeiture in the state and replace it with a criminal process. Passage of the bill would also effectively opt the state out of a program that allows police to circumvent more strict state forfeiture laws by passing cases off to the feds. Under the bill seizures could occur only if the "prosecuting authority secures a conviction of a crime that authorizes the forfeiture of property and the prosecuting authority establishes by clear and convincing evidence the property is an instrumentality of or proceeds derived directly from the crime for which the state secured a conviction." The bill would also require that seized funds be deposited in the state's general fund. Under current law, police can keep up to 60 percent of asset forfeiture proceeds, creating an incentive for "policing for profit." The bill is now before the Assembly Codes Committee.

Harm Reduction

Utah Bill to Decriminalize Fentanyl Test Strips Filed. State Sen. Jenifer Plumb (D) has filed Senate Bill 86, which would legalize the use and possession of fentanyl test strips. Under current state law, the test strips are criminalized as drug paraphernalia, but the bill would create an exemption from liability under the state Controlled Substances Act. Test strips are an increasingly popular harm reduction measure in the fight to reduce fentanyl-related drug overdoses. The bill is now in the Senate Rules Committee.

International

Former Bolivian President and Coca Grower Setting Up Regional Organization. Former Bolivian President Evo Morales, forced out of office in the wake of disputed elections in 2019, will set up the headquarters of his plurinationalist, indigenist movement in the region in Buenos Aires, Argentina. The movement will convene next week with coca growers from Colombia, Ecuador, and Peru, as well as Bolivia as Morales commences what he described as a struggle for the "plurinational peoples of Latin America." Continuing strife in Peru after the arrest and jailing of leftist President Castillo in December, as well as continuing strife in Bolivia's Santa Cruz province after the arrest of rightist Gov. Luis Fernando Camacho have placed Bolivian coca growers under unprecedented hardships. Morales rose to power as a Bolivian coca grower leader and still controls six coca grower unions in the Chapare.

For nearly four years, the Philadelphia nonprofit Safehouse has seen its effort to open a safe injection site in the city stymied by a federal court case brought against it by the Trump administration Justice Department. And although the Trump administration is now history, the Biden Justice Department has continued to pursue the case even as the number of overdose deaths in the city mounts.

But now, Safehouse and the Justice Department (DOJ) have agreed to move their case about the legality of safe injection sites out of a federal district court and into mediation before a federal magistrate, a maneuver that advocates hope can speed up the resolution of the case and get the sites up and operating.

"We agreed with the Department of Justice to move in this direction to reach a settlement and get the lawsuit resolved," Safehouse vice-president Ronda Goldfein told the Philadelphia Inquirer. While declining to further characterize confidential settlement negotiations, she said the group's goals "have not changed" and that Safehouse seeks "a resolution that all parties can live with that give us the opportunity to save lives."

The move comes as the Biden DOJ has hinted at a possible softer stance toward safe injection sites. DOJ did not go to court to block local officials in New York City from allowing two safe injection sites to open in late 2021 or to block state officials from allowing them in early 2022. And DOJ had indicated it was engaged in settlement talks with Safehouse in February 2022.

At that time, DOJ said that it was "evaluating supervised consumption sites, including discussions with state and local regulators about appropriate guardrails for such sites, as part of an overall approach to harm reduction and public safety."

But that was nearly a year ago, and Safehouse's patience is wearing thin. Just last month, after having repeatedly gone along with DOJ requests for continuances, Safehouse balked. It told the federal district court for the Eastern District of Pennsylvania that it would no longer agree to any additional delays, while the DOJ argued that it needed until February to proceed. The court compromised, requiring that DOJ reveal its position in the lawsuit by January 9.

With the mediation agreement between Safehouse and DOJ, that January 9 date is now moot, but Safehouse is convinced the move will result in a speedier resolution of the case and allow it to finally get into the business of saving lives.

"Since the DOJ commenced this litigation in 2019 until the end of 2021, more than 3,600 lives have been lost in Philadelphia to the opioid overdose crisis. Based on 2022 projections, that number will grow to almost 5,000 deaths," Safehouse said. "Safehouse and those that need its life-saving services have waited long enough."

Meanwhile, there are other signs the federal government may be warming to the harm reduction intervention. In a November report, the nonpartisan Congressional Research Service highlighted the "uncertainty" of the federal government's position on safe injection sites and suggested blockages could be overcome by approving an amendment to the annual DOJ funding bill precluding it from spending any funds to go after safe injection sites, much as has been successfully done to protect medical marijuana laws in the states.

And just days before that report was released, National Institute on Drug Abuse (NIDA) Director Nora Volkow tacitly endorsed the idea of authorizing safe consumption sites. Research has found that the intervention "has saved a significant [percentage of] patients from overdosing."

Now, if only the DOJ can find a way to get out of the way. Or if it cannot or will not, it will be time to go back to court.